Severe congenital dysfibrinogenemia (fibrinogen-Riyadh): a family study

I M al-Fawaz1, A M Gader

  • 1Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Acta Haematologica
|January 1, 1992
PubMed

Insights

A Saudi family experienced congenital severe dysfibrinogenemia, a rare bleeding disorder. The child had severe symptoms, while parents showed milder, asymptomatic effects, highlighting genetic inheritance patterns.

Area of Science:

  • Hematology
  • Genetics
  • Pediatric Medicine

Background:

  • Dysfibrinogenemia is a rare inherited bleeding disorder characterized by abnormal fibrinogen function.
  • Congenital forms can manifest with varying severity, impacting hemostasis.
  • Understanding genetic transmission is crucial for diagnosing and managing affected families.

Observation:

  • A Saudi family presented with a child exhibiting severe bleeding tendencies since birth.
  • The child's coagulation profile indicated severe dysfibrinogenemia.
  • Parents, first-degree cousins, were asymptomatic but showed milder dysfibrinogenemia.

Findings:

  • The child developed a large cephalohematoma and intracranial hemorrhage, leading to left hemiparesis.
  • Treatment with cryoprecipitate resolved the hematoma.
  • Neurological deficits persisted despite hematoma resolution.

Implications:

  • This case highlights the autosomal recessive inheritance pattern of congenital dysfibrinogenemia.
  • Early diagnosis and management are critical for preventing severe bleeding complications.
  • Genetic counseling is recommended for families with inherited bleeding disorders.